The ALIAS phase I trial: A dose-escalation and safety study of albumin therapy for acute ischemic stroke

被引：0
|
作者：
Ginsberg, MD
Hill, MD
Palesch, YY
Ryckborst, KJ
Tamariz, D
机构：
[1] Univ Miami, Sch Med, Miami, FL 33152 USA
[2] Univ Calgary, Calgary, AB T2N 1N4, Canada
[3] Med Univ S Carolina, Charleston, SC 29425 USA
来源：
STROKE | 2005年 / 36卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：420 / 420
页数：1
相关论文
共 50 条
  • [31] THE ALBUMIN IN ACUTE STROKE (ALIAS) PART 2 CLINICAL TRIAL - A RANDOMIZED MULTICENTER INVESTIGATION OF ALBUMIN-NEUROPROTECTION FOR ACUTE ISCHEMIC STROKE. 1: RATIONALE, TRIAL DESIGN AND SAFETY OUTCOMES
    Ginsberg, M. D.
    Hill, M. D.
    Palesch, Y. Y.
    Martin, R. H.
    Moy, C. S.
    Barsan, W. G.
    Ryckborst, K. J.
    Tamariz, D.
    Waldman, B. D.
    CEREBROVASCULAR DISEASES, 2013, 35 : 107 - 107
  • [32] A Phase I Dose-Escalation Trial of Single-Fraction Stereotactic Radiation Therapy for Liver Metastases
    Meyer, Jeffrey J.
    Foster, Ryan D.
    Lev-Cohain, Naama
    Yokoo, Takeshi
    Dong, Ying
    Schwarz, Roderich E.
    Rule, William
    Tian, Jing
    Xie, Yang
    Hannan, Raquibul
    Nedzi, Lucien
    Solberg, Timothy
    Timmerman, Robert
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 (01) : 218 - 224
  • [33] The ALIAS trial: A phase III randomized multicenter clinical trial of albumin-neuroprotection in acute ischemic stroke: Rationale, study design, and progress report
    Ginsberg, Myron D.
    Hill, Michael D.
    Palesch, Yuko Y.
    NEUROLOGY, 2007, 68 (12) : A185 - A185
  • [34] High dose human serum albumin for the treatment of acute ischemic stroke - A safety study
    Koch, S
    Concha, M
    Wazzan, T
    Romano, JG
    Forteza, A
    NEUROCRITICAL CARE, 2004, 1 (03) : 335 - 341
  • [35] A Phase I Dose-Escalation Trial of Single-Fraction Stereotactic Radiation Therapy for Liver Metastases
    Jeffrey J. Meyer
    Ryan D. Foster
    Naama Lev-Cohain
    Takeshi Yokoo
    Ying Dong
    Roderich E. Schwarz
    William Rule
    Jing Tian
    Yang Xie
    Raquibul Hannan
    Lucien Nedzi
    Timothy Solberg
    Robert Timmerman
    Annals of Surgical Oncology, 2016, 23 : 218 - 224
  • [36] Abciximab in acute ischemic stroke - A randomized, double-blind, placebo-controlled, dose-escalation study
    Adams, HP
    Bogousslavsky, J
    Barnathan, E
    Brott, T
    Fisher, M
    Furlan, AJ
    Graffagnino, C
    Kappelle, J
    Kothari, R
    Leclerc, JR
    Moulin, T
    Polzer, J
    Torner, J
    Worley, S
    Haley, CE
    Day, JH
    Levine, SR
    Thompson, JLP
    Sherman, DG
    Sane, DC
    Maley, JE
    Grimsman, KJ
    Maeder, M
    Clarke, WR
    Anderson, K
    Cook, R
    FitzPatrick, S
    Peeters, A
    Cras, P
    Blecic, S
    Laloux, P
    Chatel, M
    Mahagne, H
    Moulin, T
    Hacke, W
    Diener, HC
    Bogousslavsky, J
    Maeder, M
    Kappelle, LJ
    Vermulen, M
    Kwa, VIH
    Franke, CL
    Jacoby, M
    Libman, R
    Hsu, C
    Kothari, R
    Raps, EC
    Kasner, SE
    Scott, P
    Karanjia, P
    STROKE, 2000, 31 (03) : 601 - 609
  • [37] THE NEOSTEM TRIAL: AN AUSTRALIAN PHASE I DOSE-ESCALATION OF REPEATED MESENCHYMAL STEM CELL TREATMENT FOR NEONATAL STROKE
    Paton, M.
    Popat, H.
    Finch-Edmondson, M.
    Fahey, M.
    Hunt, R.
    Facer, K.
    Webb, A.
    Badawi, N.
    Novak, I.
    INTERNATIONAL JOURNAL OF STROKE, 2023, 18 (03) : 107 - 108
  • [38] Phase I dose-escalation study of milademetan in patients with relapsed or refractory acute myeloid leukemia
    Sekiguchi, Naohiro
    Kasahara, Senji
    Miyamoto, Toshihiro
    Kiguchi, Toru
    Ohno, Hitoshi
    Takagi, Taiga
    Tachibana, Masaya
    Sumi, Hiroyuki
    Kakurai, Yasuyuki
    Yamashita, Tomonari
    Usuki, Kensuke
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2023, 117 (01) : 68 - 77
  • [39] PHASE I DOSE-ESCALATION STUDY EVALUATING THE SAFETY AND PHARMACOKINETICS OF ORAL ARTESUNATE IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA (DESPARTH TRIAL)
    Vandewynckel, Y. -P.
    Rombauts, K.
    Verhelst, X.
    Van Bortel, L.
    De Spiegeleer, B.
    Geerts, A.
    Van Vlierberghe, H.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S860 - S860
  • [40] Phase I dose-escalation study of milademetan in patients with relapsed or refractory acute myeloid leukemia
    Naohiro Sekiguchi
    Senji Kasahara
    Toshihiro Miyamoto
    Toru Kiguchi
    Hitoshi Ohno
    Taiga Takagi
    Masaya Tachibana
    Hiroyuki Sumi
    Yasuyuki Kakurai
    Tomonari Yamashita
    Kensuke Usuki
    International Journal of Hematology, 2023, 117 : 68 - 77
12345